Dr. Orme is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Division of Medical Oncology
200 1st St SW
Rochester, MN 55905Phone+1 507-255-5123
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2016 - 2019
University of Texas Southwestern Medical SchoolClass of 2016
Certifications & Licensure
MN State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award Prostate Cancer Foundation, 2022
Clinical Trials
- Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors Start of enrollment: 2021 Apr 01
Publications & Presentations
PubMed
- 1 citationsHeterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis.Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz, Arifa Bibi, Muhammad Ali Khan, Manal Imran
European Urology. 2025-01-22 - PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts.Jack Andrews, Yohan Kim, Edlira Horjeti, Ali Arafa, Heather Gunn
Clinical Cancer Research. 2025-01-16 - Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.Pradeep S Chauhan, Irfan Alahi, Savar Sinha, Elisa M Ledet, Ryan Mueller
Clinical Cancer Research. 2025-01-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
